Biotech Archives - Page 793 of 795

1 minute read

InflaRx’s Stock Gains Following FDA Fast Track Status To Skin Disease Drug

July 6, 8:53 AM

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

IFRX

3 minute read

Sheba Medical Center and Enlivex Announce Dosing Of The First Patient In Phase I/II Trial Evaluating Allocetra Combined With Chemotherapy In Patients With Peritoneal Metastases Arising From Solid Cancers

By Bill Haddad

July 6, 8:37 AM

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects in solid tumor models Sheba Medical Center was

ENLV

1 minute read

Applied Molecular Transport Announces Top-line Phase 2 Results From MARKET Combination Trial Of Oral AMT-101 In Patients With Moderate-to-Severe Ulcerative Colitis

By Benzinga Newsdesk

July 6, 8:05 AM

– Similar clinical remission rates observed of 31.8% (7/22) in patients receiving combination (AMT-101 and adalimumab) versus 33.3% (9/27) in patients receiving placebo plus adalimumab at week

AMTI

3 minute read

Caladrius Biosciences And Cend Therapeutics Highlights Publication Of Pancreatic Cancer Trial Data In The Lancet Gastroenterology And Hepatology

By Bill Haddad

July 6, 8:03 AM

Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, and Cend

CLBS

3 minute read

Vera Therapeutics Completes Patient Enrollment In Phase 2b ORIGIN Clinical Trial Of Atacicept For The Treatment of IgA Nephropathy

By Bill Haddad

July 6, 7:31 AM

Vera Therapeutics, Inc. (NASDAQ:VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological disease, today announced completion of

VERA

1 minute read

FDA Temporarily Suspends Banning Order On Juul’s E-Cigarettes

By Vandana Singh

July 6, 7:13 AM

The FDA temporarily suspended its ban on sales of the popular e-cigarette maker Juul, backed by Altria Group Inc

2 minute read

Affordable Housing, Less Carbon: DOE Funds Texas A&M University 3D-Printed Hempcrete Project

By Nicolas Jose Rodriguez

July 1, 5:26 PM

The Department of Energy (DOE) has awarded Texas A&M University $3.47 million to support a project to 3D print a bio-aggregate composite consisting of hemp hurd and a lime-based binder, also known as hempcrete, a material with the potential to lower the environmental impact of traditional construction and make housing more affordable and available,

OWPC

1 minute read

Scholar Rock To Present Phase 3 SAPPHIRE Trial Design At The 17th International Congress On Neuromuscular Diseases

By Benzinga Newsdesk

July 1, 4:01 PM

Scholar Rock (NASDAQ:SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced an e-poster

SRRK